openPR Logo
Press release

Asia-Pacific Continuous Bioprocessing Market Poised to Surpass $181.1 Million by 2030

02-05-2024 01:32 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Meticulous Research®

Asia-Pacific Continuous Bioprocessing Market Poised

Redding California, February 5, 2024- Meticulous Research, a renowned global market research firm, is proud to present its latest report, "Asia-Pacific Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), and End User (Pharmaceuticals, Biotechnology, CROs)-Forecast to 2030." Released on xx September 2023, the report anticipates a remarkable Compound Annual Growth Rate (CAGR) of 28.9%, propelling the Asia-Pacific continuous bioprocessing market to a valuation of $181.1 million by the year 2030.

Download Free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5682

Key Growth Drivers:
The ascending trajectory of the Asia-Pacific continuous bioprocessing market is underpinned by several factors, including the burgeoning landscape of biopharmaceuticals in Asian countries. A surge in manufacturing and research-related outsourcing of biopharmaceuticals, expansions in Contract Development and Manufacturing Organizations (CDMOs), advancements in bioprocessing technologies, and an uptick in partnerships and collaborations among industry players for biopharma manufacturing collectively contribute to the market's robust growth. Moreover, the paradigm shift towards bioprocessing 4.0 and the increasing adoption of personalized medicines present significant growth opportunities.

Challenges and Restraints:
Despite the optimistic outlook, challenges persist in the form of limitations associated with continuous bioprocessing. Furthermore, the hesitancy among manufacturers to transition from batch manufacturing to continuous manufacturing poses challenges for market players.

Key Market Players:
Prominent players steering the Asia-Pacific continuous bioprocessing market include 3M (U.S.), Cytiva (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), Solida Biotech GmBH (Germany), Electrolab Biotech Limited (U.K.), Biowest (France), and Bionet (U.S.).

Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5682

The Asia-Pacific continuous bioprocessing market is meticulously segmented by Meticulous Research across Product (Filtration Systems and Consumables, Chromatography Systems and Consumables, Cell Culture Media, Buffers, and Reagents, Incubators and Shakers, Bioreactors, Centrifuges, Sterilizers, and Other Instruments and Consumables), Application (Commercial Applications [Monoclonal Antibodies (mAbs) Production, Cell and Gene Therapy Production, Vaccine Manufacturing, Plasma Fractionation, and Recombinant Protein Production], R&D), and End User (Pharmaceutical and Biotechnology Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs), and Academic and Research Institutes).

In 2023, the Filtration Systems and Consumables segment is forecasted to dominate the market, driven by its widespread utilization in various biopharmaceutical processing steps. The highest revenue share of this segment is attributed to the recurring use of filtration at every step in bioprocessing and advancements in filtration technologies.

Commercial Applications are expected to command the largest market share in 2023, buoyed by growing initiatives supporting biopharmaceutical adoption, increased biopharmaceutical manufacturing outsourcing, and accelerated developments in personalized therapies.
The Pharmaceutical and Biotechnology Companies segment is anticipated to hold the largest market share among end users in 2023, owing to capacity expansions by biopharmaceutical manufacturers and the widespread adoption of biopharmaceutical processing equipment for bioproduction in the pharmaceutical and biotechnology sectors.

Quick Buy: https://www.meticulousresearch.com/Checkout/41500504
Market Outlook by Country:

This comprehensive research report assesses the continuous bioprocessing market in Asia-Pacific, covering countries such as China, India, Japan, Singapore, South Korea, Australia, New Zealand, Indonesia, and the Rest of Asia-Pacific. In 2023, China is poised to lead the market, driven by a growing focus on the pharmaceutical and biopharmaceutical industry, increased investment in biosimilars, and supportive initiatives for CDMOs.

Key Report Highlights:
The report answers pivotal questions about high-growth market segments, historical market trends, forecasts for 2023-2030, major market drivers, restraints, opportunities, and challenges in the Asia-Pacific continuous bioprocessing market. Additionally, it profiles major players, analyzes the competitive landscape, and provides insights into recent developments and strategies adopted by key players in the Asia-Pacific continuous bioprocessing market.

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Continuous Bioprocessing Market Poised to Surpass $181.1 Million by 2030 here

News-ID: 3373004 • Views:

More Releases from Meticulous Research®

Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticulous Research®
Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticul …
The nutraceutical products market is witnessing steady and significant growth, driven by a rising awareness of health, nutrition, and disease prevention. Between 2023 and 2030, the market is projected to expand at a compound annual growth rate of 7.8%, ultimately reaching a value of $691.87 billion by the end of the forecast period. This growth reflects a major shift in consumer mindset, as individuals increasingly seek products that offer both
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insights to 2030 | Meticulous Research®
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insig …
The way we feed our livestock is changing, and feed additives are at the heart of that transformation. Over the next decade, the global feed additives market is expected to surpass $51 billion, fueled by rising demand for meat and dairy products, concerns over animal health, and a push toward more sustainable farming practice. Farmers today are no longer just feeding animals they are strategically nourishing them to improve growth,
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | Meticulous Research®
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | M …
The home medical equipment market is growing steadily and is projected to reach nearly $63 billion by 2030. These devices are designed to help people manage their health at home, allowing patients to remain independent while receiving the care they need. From respiratory devices to mobility aids, these products make it possible for individuals to maintain a better quality of life without relying entirely on hospital care. They are especially
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regional Insights to 2030 | Meticulous Research®
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regi …
The membrane filtration technologies market is steadily expanding, with expectations to hit $22.2 billion by 2030. Over the past few years, industries and municipalities alike have faced increasing pressure to manage water more efficiently. Water scarcity, environmental regulations, and operational needs have created a situation where traditional water treatment methods are no longer sufficient. Businesses are turning toward membrane filtration technologies as a solution that offers both reliability and precision. Water

All 5 Releases


More Releases for Biotech

Global Agricultural Biotech Market Analysis By Top Keyplayers - Agriland Biotech …
Market Overview The global agricultural biotech market, valued at USD 103.2 billion in 2023, is projected to reach USD 213.3 billion by 2031, growing at a CAGR of 9.5% from 2024 to 2031. Biotechnology in agriculture enhances productivity through genetic modification, producing crops with higher yields, pest and disease resistance, and better nutritional content. Recent advancements like CRISPR-Cas9 have revolutionized crop development, offering precise and efficient genetic enhancements. Emerging markets with
By Company Kingherbs Artemis NutriBotanica Kemin Vita Forte Alpspure Reindeer Bi …
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global Acerola Cherry Extract Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global Acerola Cherry Extract market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides
Phycobiliproteins Market | Aim Grow Biotech Co., Ltd, Algapharma Biotech, Algene …
The global phycobiliproteins market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the phycobiliproteins market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the phycobiliproteins market.
Biotechnology-Based Chemical Market Size 2022: Kemin Europa, Clariant, JC Biotec …
Biotechnology-Based Chemical Market research report provides valuable insights by analyzing market trends and market scenarios over a defined period. It also presents manufacturing details like sales, volume, revenue, price, and gross margin. Furthermore, the import-export analysis, pricing analysis is also included in the report to understand the product demand and service. Finally, it also provides end-user application analysis, which delivers revenue, growth percentage of the product across the different applications.
Global Acetaminophen (Paracetamol) Market 2020 | Genesis Biotech, M.M. Pharma, A …
The Global Acetaminophen (Paracetamol) Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of Global Acetaminophen (Paracetamol) Market.The Key manufactures involved in this market
Global Ginkgetin Market 2019 - Hunan Nutramax, Shaanxi Pioneer Biotech, Xi'an So …
Ginkgetin is an extract from ginkgo biloba. Scope of the Report: Ginkgetin can dilate blood vessels, promote blood circulation, enhance immunity, and promote cerebral blood circulation and cell metabolism. The worldwide market for Ginkgetin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017. This report focuses on the Ginkgetin in global market, especially in North